Free Republic

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.Ozempic, Mounjaro, and other glucagon-like peptide-1 medications, otherwise known as GLP-1s, are changing how Americans shop for groceries. In early January, Food & Wine published a story about how food companies are releasing all-new products or reimagining the marketing of old ones to appeal to more GLP-1 users who may be looking for specific nutrition needs like high-protein, high-fiber foods. In that story, we mentioned one tiny but important research paper by Cornell University that showed that households with at least one GLP-1...

Weight-loss drugs like Ozempic have gained popularity recently for their ability to support weight loss, which can mostly be attributed to their appetite-suppressing effects. Ozempic is in a class of drugs called GLP-1 receptor agonists, which mimic the hormone GLP-1. This slows down gastric emptying and sends signals of fullness to the brain. Basically, this means food stays in the stomach longer and tells the brain that you are full and don't need more food. This leads to less calorie consumption and, eventually, weight loss.